Novavax Vaccine Study For Children

covid vaccine for children

We are happy to announce that the Novavax vaccine is being reviewed by the FDA for Emergency Use Authorization in adults, and they are opening a research study to children ages 12 to 17. We expect children ages 6 to 11 will be enrolling shortly. If you or someone you know is interested in enrolling their child in the study, … Read More